The group’s principal activity is to provide development and marketing of clinical solutions for spinal market segments. The group’s products includes the StaXx® XD expandable device, the CapSure® PS spine system, the StaXx® FX structural kyphoplasty system and the NuCore® injectable nucleus. The group operates from the United States.
